Frederick J. Fritz
Mr. Fritz was appointed to the Board of Directors in July 2011. He is the CEO and Founder of NeuroDx, a development-stage diagnostic device company focused on the neurosurgery market. Mr. Fritz joined NeuroDx from Valeo Medical, a biotech company he founded in 2003, to develop the world’s first noninvasive diagnostic test for endometriosis. Prior to that, Mr. Fritz was President and CEO of Songbird Hearing, a medical device company spin-off of Sarnoff Corp. Mr. Fritz began his career in marketing management and new product development. He joined Schering Plough’s Wesley Jessen in 1985 as Vice President, Marketing and Sales. He was promoted to general manager of Schering’s OTC pharmaceutical business in 1988 and of the podiatric products business in 1990. Additionally, Mr. Fritz was President of Coleman North America from 1995-1997. He holds an Engineering degree from the University of Illinois, from which he was graduated Summa Cum Laude, and an MBA from Harvard Business School.